We are live on ! Find out more
ACM

Atika Capital Management Portfolio holdings

AUM $796M
1-Year Est. Return 167.57%
This Fund
S&P 500
This Quarter Est. Return
+23.47%
1 Year Est. Return
+167.57%
3 Year Est. Return
+553.47%
5 Year Est. Return
+1,283.26%
10 Year Est. Return
+44,203.78%
AUM
$558M
AUM Growth
+$37.6M
Cap. Flow
-$24.1M
Cap. Flow %
-4.32%
Top 10 Hldgs %
33.83%
Holding
112
New
24
Increased
27
Reduced
29
Closed
27

Top Buys

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$6.49M
2
MOH icon
Molina Healthcare
MOH
+$6.13M
3
CNC icon
Centene
CNC
+$5.55M
4
DXCM icon
DexCom
DXCM
+$5.21M
5
BIO icon
Bio-Rad Laboratories Class A
BIO
+$5.12M

Top Sells

Rank Stock Value
1
WW
WW International
WW
+$12.1M
2
ETSY icon
Etsy
ETSY
+$6.63M
3
ADSK icon
Autodesk
ADSK
+$5.08M
4
META icon
Meta Platforms (Facebook)
META
+$4.16M
5
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$4.15M

Sector Composition

Rank Sector Weight
1 Healthcare 36.91%
2 Technology 14.91%
3 Communication Services 9.68%
4 Consumer Discretionary 8.3%
5 Materials 2.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ATVI
76
DELISTED
Activision Blizzard
ATVI
$2M 0.36%
24,000
+6,000
+33% +$455K
FWONK icon
77
CALL
Liberty Media Series C
FWONK
$24.1B
$1.49M 0.27%
41,372
– –
ASIX icon
78
AdvanSix
ASIX
$546M
$1.36M 0.24%
40,000
-55,000
-58% -$1.97M
NTRA icon
79
Natera
NTRA
$39.4B
$1.2M 0.21%
+50,000
New +$1.21M
ARNA
80
CALL
DELISTED
Arena Pharmaceuticals Inc
ARNA
$1.15M 0.21%
25,000
+6,300
+34% +$255K
CRSP icon
81
CALL
CRISPR Therapeutics
CRSP
$5.07B
– –
-20,000
Closed -$1.05M
SGI
82
CALL
Somnigroup International
SGI
$14.6B
$794K 0.14%
60,000
– –
PTLA
83
CALL
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$665K 0.12%
+25,000
New +$816K
MDCO
84
DELISTED
Medicines Co
MDCO
$599K 0.11%
20,000
+9,187
+85% +$346K
PGEN icon
85
PUT
Precigen
PGEN
$2.47B
$344K 0.06%
+20,000
New +$297K
NVTR
86
DELISTED
Nuvectra Corporation Common Stock
NVTR
$220K 0.04%
+10,000
New +$192K
ALNY icon
87
Alnylam Pharmaceuticals
ALNY
$30.6B
– –
-23,000
Closed -$2.27M
ASND icon
88
Ascendis Pharma A/S
ASND
$16B
– –
-15,700
Closed -$1.04M
CI icon
89
CALL
Cigna
CI
$71.5B
– –
-25,000
Closed -$4.25M
CRSP icon
90
CRISPR Therapeutics
CRSP
$5.07B
– –
-52,000
Closed -$2.72M
CRTO icon
91
PUT
Criteo S.A. Ordinary Shares
CRTO
$857M
– –
-30,000
Closed -$986K
DIN icon
92
CALL
Dine Brands
DIN
$453M
– –
-50,000
Closed -$3.74M
DOCU
93
PUT
DocuSign
DOCU
$11B
– –
-72,000
Closed -$3.81M
DXCM icon
94
CALL
DexCom
DXCM
$31.2B
– –
-160,000
Closed -$3.8M
EEM icon
95
PUT
iShares MSCI Emerging Markets ETF
EEM
$29.5B
– –
-50,000
Closed -$2.17M
FND icon
96
Floor & Decor
FND
$6.68B
– –
-55,000
Closed -$2.71M
ILF icon
97
PUT
iShares Latin America 40 ETF
ILF
$3.82B
– –
-100,000
Closed -$2.96M
IRWD icon
98
Ironwood Pharmaceuticals
IRWD
$683M
– –
-195,816
Closed -$3.13M
PBYI icon
99
Puma Biotechnology
PBYI
$397M
– –
-62,000
Closed -$3.67M
PEN icon
100
Penumbra
PEN
$12.7B
– –
-22,500
Closed -$3.11M
1 2 3
4
5

Similar funds

AGA
Arkos Global Advisors Houston, Texas $797M AUM 15.28% 1-Year Est. Return
ACM
Ashe Capital Management Englewood Cliffs, New Jersey $797M AUM 4.79% 1-Year Est. Return
LSA
L & S Advisors Los Angeles, California $795M AUM 52.77% 1-Year Est. Return
GWA
Geometric Wealth Advisors Washington, District of Columbia $799M AUM 22.19% 1-Year Est. Return
HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return
SC
Soundwatch Capital Rowayton, Connecticut $793M AUM 15.45% 1-Year Est. Return
LWM
Liberty Wealth Management Oakland, California $800M AUM 20.44% 1-Year Est. Return
NW
Naviter Wealth Little Rock, Arkansas $801M AUM 22.2% 1-Year Est. Return

Atika Capital Management's Q3 2018 Portfolio in Review

As of Q3 2018, Atika Capital Management held 112 positions worth $558M, up 7.2% from $520M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Atika Capital Management withdrew a net $24.1M in Q3 2018, closing 27 positions and reducing 29 holdings. Its most notable exit was WW International, an estimated $12.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 26% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Atika Capital Management opened a new position in Elevance Health worth $6.85M.

  • Atika Capital Management's largest Q3 2018 buy was Elevance Health: 25,000 shares worth $6.85M.
  • Atika Capital Management added most to DexCom in Q3 2018, an estimated $5.21M increase.
  • Atika Capital Management's biggest Q3 2018 reduction was Etsy, cutting an estimated $6.63M.
  • Atika Capital Management fully exited WW International in Q3 2018, selling an estimated $12.1M.
  • Atika Capital Management's ten largest holdings make up 34% of its $558M portfolio in Q3 2018.
  • Atika Capital Management opened 24 new positions and closed 27 in Q3 2018.
  • Atika Capital Management's portfolio value rose 7.2% quarter-over-quarter to $558M.

Based on Atika Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.